Cellosaurus logo
expasy logo
Due to maintenance work, this service will be unavailable from Mon Nov 11 17:30 until Tue Nov 12 09:00 CET. Apologies for the inconvenience.

Cellosaurus SNU-484 Ola-R (CVCL_C1NA)

[Text version]
Cell line name SNU-484 Ola-R
Synonyms SNU-484/olaparib-resistant; Olaparib-resistant SNU-484
Accession CVCL_C1NA
Resource Identification Initiative To cite this cell line use: SNU-484 Ola-R (RRID:CVCL_C1NA)
Comments Population: Korean.
Selected for resistance to: ChEBI; CHEBI:83766; Olaparib.
Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
Sequence variations
  • Mutation; HGNC; 11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Homozygous (from parent cell line).
Disease Gastric adenocarcinoma (NCIt: C4004)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0100 (SNU-484)
Sex of cell Male
Age at sampling 53Y
Category Cancer cell line
Publications

PubMed=32028591; DOI=10.3390/cancers12020334; PMCID=PMC7072281
Kim J.W., Min A., Im S.-A., Jang H., Kim Y.J., Kim H.-J., Lee K.-H., Kim T.-Y., Lee K.W., Oh D.-Y., Kim J.-H., Bang Y.-J.
TDP1 and TOP1 modulation in olaparib-resistant cancer determines the efficacy of subsequent chemotherapy.
Cancers (Basel) 12:334.1-334.17(2020)

Cross-references
Cell line databases/resources cancercelllines; CVCL_C1NA
Encyclopedic resources Wikidata; Q114313041
Entry history
Entry creation22-Sep-2022
Last entry update05-Oct-2023
Version number5